Literature DB >> 9671251

Sexually transmitted diseases in Ulaanbaatar, Mongolia.

J R Schwebke1, T Aira, N Jordan, P E Jolly, S H Vermund.   

Abstract

Although human immunodeficiency virus (HIV) rates are increasing rapidly in Asia, a full understanding of the extent of other sexually transmitted diseases (STDs) in many of these areas is lacking. There have been anecdotes of rising rates of STDs in Mongolia, a country thus far relatively unaffected by HIV. To further the understanding of STDs, a prevalence study was conducted in the STD clinic in Ulaanbaatar, the capital and largest city in Mongolia. Among 260 patients, the prevalence of gonorrhoea, chlamydia and syphilis was 31.1%, 8.1% and 8.6% respectively for males and 10.3%, 9.9% and 6.0% for females. Sixty-seven per cent of females had trichomoniasis and 19.7% of males had non-gonococcal urethritis (NGU). Forty-two per cent of gonococcal isolates had plasmid mediated resistance to penicillin, and chromosomal resistance to penicillin, tetracycline, and ciprofloxacin was documented. No patients were infected with HIV. STDs are a significant problem in Mongolia. Improved control efforts are urgently needed to prevent the emergence of HIV.

Entities:  

Keywords:  Asia; Behavior; Demographic Factors; Developing Countries; Diseases; Eastern Asia; Heterosexuals--men; Heterosexuals--women; Infections; Measurement; Mongolia; Population; Population Characteristics; Prevalence; Reproductive Tract Infections; Research Methodology; Research Report; Sex Behavior; Sexually Transmitted Diseases; Urban Population

Mesh:

Year:  1998        PMID: 9671251      PMCID: PMC2753240          DOI: 10.1258/0956462981922269

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  15 in total

1.  Norfloxacin resistant Neisseria gonorrhoeae in North America.

Authors:  K H Yeung; J R Dillon
Journal:  Lancet       Date:  1990-09-22       Impact factor: 79.321

Review 2.  Evolution of AIDS policy in the Soviet Union. II. The AIDS epidemic and emergency measures.

Authors:  Z A Medvedev
Journal:  BMJ       Date:  1990-04-07

3.  Efficacy of selected diagnostic tests for sexually transmitted diseases.

Authors:  R B Rothenberg; R Simon; E Chipperfield; R D Catterall
Journal:  JAMA       Date:  1976-01-05       Impact factor: 56.272

4.  The emerging epidemic of HIV infection and AIDS in Asia and the Pacific.

Authors:  J M Kaldor; W Sittitrai; T J John; T Kitamura
Journal:  AIDS       Date:  1994       Impact factor: 4.177

5.  Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.

Authors:  R N Jones; T L Gavan; C Thornsberry; P C Fuchs; E H Gerlach; J S Knapp; P Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

6.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

7.  Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.

Authors:  J S Knapp; J A Hale; S W Neal; K Wintersheid; R J Rice; W L Whittington
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

8.  Accuracy of presumptive criteria for culture diagnosis of Neisseria gonorrhoeae in low-prevalence populations of women.

Authors:  M P Smeltzer; J W Curran; S T Brown; J Pass
Journal:  J Clin Microbiol       Date:  1980-05       Impact factor: 5.948

9.  1993 sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1993-09-24

10.  Trends in susceptibility of Neisseria gonorrhoeae to ceftriaxone from 1985 through 1991.

Authors:  J R Schwebke; W Whittington; R J Rice; H H Handsfield; J Hale; K K Holmes
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

View more
  10 in total

1.  Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.

Authors:  Janelle M Wright; Linda A Dunn; Zygmunt Kazimierczuk; Anita G Burgess; Kenia G Krauer; Peter Upcroft; Jacqueline A Upcroft
Journal:  Parasitol Res       Date:  2010-06-09       Impact factor: 2.289

Review 2.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 3.  Drug targets and mechanisms of resistance in the anaerobic protozoa.

Authors:  P Upcroft; J A Upcroft
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

4.  InTray GC medium versus modified Thayer-Martin agar plates for diagnosis of gonorrhea from endocervical specimens.

Authors:  A Beverly; J R Bailey-Griffin; J R Schwebke
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

5.  Systematizing planning and formative phases of HIV prevention research: Case studies from Brazil, Mongolia, and Kazakhstan.

Authors:  Rogério M Pinto; Anya Y Spector; Susan S Witte; Louisa Gilbert
Journal:  Glob Soc Welf       Date:  2014-09

6.  Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function.

Authors:  Bibhuti N Singh; Gary R Hayes; John J Lucas; Ulf Sommer; Nelly Viseux; Ekaterina Mirgorodskaya; Radiana T Trifonova; Rosaria Rita S Sassi; Catherine E Costello; Raina N Fichorova
Journal:  Glycoconj J       Date:  2008-07-06       Impact factor: 2.916

7.  Prevalence of sexually transmitted infections (Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and human papillomavirus) in female attendees of a sexually transmitted diseases clinic in Ulaanbaatar, Mongolia.

Authors:  S M Garland; S N Tabrizi; S Chen; C Byambaa; K Davaajav
Journal:  Infect Dis Obstet Gynecol       Date:  2001

8.  Adult female syphilis prevalence, congenital syphilis case incidence and adverse birth outcomes, Mongolia 2000-2016: Estimates using the Spectrum STI tool.

Authors:  Erdenetungalag Enkhbat; Eline L Korenromp; Jugderjav Badrakh; Setsen Zayasaikhan; Purevsuren Baya; Enkhjargal Orgiokhuu; Narantuya Jadambaa; Sergelen Munkhbaatar; Delgermaa Khishigjargal; Narantuya Khad; Guy Mahiané; Naoko Ishikawa; Davaalkham Jagdagsuren; Melanie M Taylor
Journal:  Infect Dis Model       Date:  2018-03-09

Review 9.  Emerging infectious diseases in Mongolia.

Authors:  John R Ebright; Togoo Altantsetseg; Ravdan Oyungerel
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

10.  Trends in adult chlamydia and gonorrhoea prevalence, incidence and urethral discharge case reporting in Mongolia from 1995 to 2016 - estimates using the Spectrum-STI model.

Authors:  Jugderjav Badrakh; Setsen Zayasaikhan; Davaalkham Jagdagsuren; Erdenetungalag Enkhbat; Narantuya Jadambaa; Sergelen Munkhbaatar; Melanie Taylor; Jane Rowley; Guy Mahiané; Eline Korenromp
Journal:  Western Pac Surveill Response J       Date:  2017-12-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.